Company / Net Income
Niagen Bioscience, Inc. Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
$17.4M
FY2025
5-year range
-$27.1M / $17.4M
FY2021-FY2025
Trend
+452.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Income changed +452% YoY in FY2025, a notable deviation from the 9-year average annual change of +10%.
Based on SEC 10-K filings.
$17M in FY2025.
Improved from -$17M to $17M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Niagen Bioscience, Inc.'s net income has grown for 3 consecutive years.
- In FY2025, net income increased 452.0% year-over-year.
- Lowest net income in the period was in FY2020.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $17.4M | +452.0% |
| FY2024 | -$4.9M | +70.1% |
| FY2023 | -$16.5M | +39.0% |
| FY2022 | -$27.1M | -36.2% |
| FY2021 | -$19.9M | +38.0% |
| FY2020 | -$32.1M | +0.0% |
| FY2019 | -$32.1M | -182.5% |
| FY2018 | -$11.4M | +0.0% |
| FY2017 | -$11.4M | -288.6% |
| FY2016 | -$2.9M | -5.7% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026